Gene expression signature of advanced pancreatic ductal adenocarcinoma using low density array on endoscopic ultrasound-guided fine needle aspiration samples

Pancreatology

Volumn 12, Issue 1, 2012, Pages 27-34

  Bournet, B ^a,b   Pointreau, A ^a,b   Souque, A ^a   Oumouhou, N ^c   Muscari, F ^a,b   Lepage, B ^c   Senesse, P ^d   Barthet, M ^e   Lesavre, N ^e   Hammel, P ^f   Levy, P ^f   Ruszniewski, P ^f   Cordelier, P ^a   Buscail, L ^a,b  

^a CHU RANGUEIL   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

^c UNIVERSITÉ PAUL SABATIER   (France)

^d CENTRE VAL D AURELLE   (France)

^e HÔPITAL NORD   (France)

^f BEAUJON HOSPITAL   (France)

Author keywords

Advanced pancreatic cancer; Cancer invasion; Fine needle aspiration; Pseudotumoural Chronic pancreatitis; TaqMann low density array

Indexed keywords

CYTOKERATIN 17; CYTOKERATIN 7; MATRILYSIN; MESOTHELIN; PLASMINE ACTIVATOR UROKINASE PROTEIN; PLASMINOGEN ACTIVATOR TISSUE PROTEIN; PROTEIN; S100 BINDING PROTEIN P; STROMELYSIN 3; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; AGED; ARTICLE; ASPIRATION BIOPSY; CHRONIC PANCREATITIS; CLINICAL EFFECTIVENESS; ENDOSCOPIC ECHOGRAPHY; FEASIBILITY STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROSPECTIVE PAYMENT; SENSITIVITY AND SPECIFICITY;

EID: 84862180769     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1016/j.pan.2011.12.003     Document Type: Article

References (34)

1. Warshaw AL, Fernandez-del-Castillo C. Pancreatic carcinoma. N Eng J Med 1992;326:455-65.
2. Bournet B, Souque A, Senesse P, Assenat E, Barthet M, Lesavre N, et al. Endoscopic ultrasound-guided fine-needle aspiration biopsy coupled with KRAS mutation assay to distinguish pancreatic cancer from pseudotumoral chronic pancreatitis. Endoscopy 2009;41:552-7.
3. Wiersema MJ. Accuracy of endoscopic ultrasound in diagnosing and staging pancreatic carcinoma. Pancreatology 2001;1:625-32. (Pubitemid 33674958)
4. Buscail L, Faure P, Bournet B, Selves J, Escourrou J. Interventional endoscopic ultrasound in pancreatic diseases. Pancreatology 2006;6:7-16.
5. Bhutani MS, Logroño R. Endoscopic ultrasound-guided fine-needle aspiration cytology for diagnosis above and below the diaphragm. J Clin Ultrasound 2005;33:401-11. (Pubitemid 41540990)
6. Torrisani J, Bournet B, du Rieu MC, Bouisson M, Souque A, Escourrou J, et al. Let-7 microRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression. Hum Gene Ther 2009; 20:831-44.
7. Crnogorac-Jurcevic T, Efthimiou E, Capelli P, Blaveri E, Baron A, Terris B, et al. Gene expression profiles of pancreatic cancer and stromal desmoplasia. Oncogene 2001;20:7437-46. (Pubitemid 33078216)
8. Iacobuzio-Donahue CA, Maitra A, Shen-Ong GL, van Heek T, Ashfaq R, Meyer R, et al. Discovery of novel tumor markers of pancreatic cancer using global gene expression technology. Am J Pathol 2002;160:1239-49. (Pubitemid 34411628)
9. Logsdon CD, Simeone DM, Binkley C, Arumugam T, Greenson JK, Giordano TJ, et al. Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. Cancer Res 2003;63:2649-57. (Pubitemid 36605209)
10. Sato N, Maitra A, Fukushima N, van Heek NT, Matsubayashi H, Iacobuzio- Donahue CA, et al. Frequent hypomethylation of multiple genes overexpressed in pancreatic ductal adenocarcinoma. Cancer Res 2003;63:4158-66. (Pubitemid 36917941)
11. Crnogorac-Jurcevic T, Missiaglia E, Blaveri E, Gangeswaran R, Jones M, Terris B, et al. Molecular alterations in pancreatic carcinoma: expression profiling shows that dysregulated expression of S100 genes is highly prevalent. J Pathol 2003;201:63-74. (Pubitemid 37121204)
12. Laurell H, Bouisson M, Berthelemy P, Rochaix P, Dejean S, Besse P, et al. Identification of biomarkers of human pancreatic adenocarcinomas by expression profiling and validation with gene expression analysis in endoscopic ultrasound-guided fine needle aspiration samples. World J Gastroenterol 2006;12:3344-51. (Pubitemid 43933778)
13. Friess H, Ding J, Kleeff J, Liao Q, Berberat PO, Hammer J, et al. Identification of disease-specific genes in chronic pancreatitis using DNA array technology. Ann Surg 2001;234:769-78.
14. Iacobuzio-Donahue CA, Maitra A, Olsen M, Lowe AW, van Heek NT, Rosty C, et al. Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. Am J Pathol 2003;162:1151-62. (Pubitemid 36350660)
15. Ramachandran V, Arumugam T, Hwang RF, Greenson JK, Simeone DM, Logsdon CD. Adrenomedullin is expressed in pancreatic cancer and stimulates cell proliferation and invasion in an autocrine manner via the adrenomedullin receptor, ADMR. Cancer Res 2007;67:2666-75. (Pubitemid 46548954)
16. Niedergethmann M, Alves F, Neff JK, Heidrich B, Aramin N, Li L, et al. Gene expression profiling of liver metastases and tumour invasion in pancreatic cancer using an orthotopic SCID mouse model. Br J Cancer 2007;97:1432-40. (Pubitemid 350114784)
17. Sarbia M, Fritze F, Geddert H, von Weyhern C, Rosenberg R, Gellert K. Differentiation between pancreaticobiliary and upper gastrointestinal adenocarcinomas: is analysis of cytokeratin 17 expression helpful? Am J Clin Pathol 2007;128:255-9. (Pubitemid 47262623)
18. Bramhall SR, Stamp GW, Dunn J, Lemoine NR, Neoptolemos JP. Expression of collagenase (MMP2), stromelysin (MMP3) and tissue inhibitor of the metalloproteinases (TIMP1) in pancreatic and ampullary disease. Br J Cancer 1996; 73:972-8. (Pubitemid 26116751)
19. Bharadwaj U, Li M, Chen C, Yao Q. Mesothelin-induced pancreatic cancer cell proliferation involves alteration of cyclin E via activation of signal transducer and activator of transcription protein 3. Mol Cancer Res 2008;6:1755-65.
20. Missiaglia E, Blaveri E, Terris B, Wang YH, Costello E, Neoptolemos JP, et al. Analysis of gene expression in cancer cell lines identifies candidate markers for pancreatic tumorigenesis and metastasis. Int J Cancer 2004; 112:100-12. (Pubitemid 39249497)
21. Whiteman HJ, Weeks ME, Dowen SE, Barry S, Timms JF, Lemoine NR, et al. The role of S100P in the invasion of pancreatic cancer cells is mediated through cytoskeletal changes and regulation of cathepsin D. Cancer Res 2007;67: 8633-42. (Pubitemid 47437439)
22. Guweidhi A, Kleeff J, Giese N, El Fitori J, Ketterer K, Giese T, et al. Enhanced expression of 14-3-3sigma in pancreatic cancer and its role in cell cycle regulation and apoptosis. Carcinogenesis 2004;25:1575-85. (Pubitemid 39214299)
23. Shi Y, Hata A, Lo RS, Massagué J, Pavletich NP. A structural basis for mutational inactivation of the tumour suppressor Smad4. Nature 1997;388:87-93. (Pubitemid 27283894)
24. Buscail L, Saint-Laurent N, Chastre E, Vaillant JC, Gespach C, Capella G, et al. Loss of sst2 somatostatin receptor gene expression in human pancreatic and colorectal cancer. Cancer Res 1996;56:1823-7. (Pubitemid 26118217)
25. Suehara N, Mizumoto K, Muta T, Tominaga Y, Shimura H, Kitajima S, et al. Telomerase elevation in pancreatic ductal carcinoma compared to nonmalignant pathological states. Clin Cancer Res 1997;3:993-8. (Pubitemid 27252949)
26. Hayer SP, di Magliano MP, Heiser PW, Nielsen CM, Roberts DJ, Lauwers GY, et al. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 2003;425:851-6. (Pubitemid 37355945)
27. Goulter AB, Harmer DW, Clark KL. Evaluation of low density array technology for quantitative parallel measurement of multiple genes in human tissue. BMC Genomics 2006;7:34.
28. Steg A, Wang W, Blanquicett C, Grunda JM, Eltoum IA, Wang K, et al. Multiple gene expression analyses in paraffin-embedded tissues by TaqMan low-density array: application to hedgehog and Wnt pathway analysis in ovarian endometrioid adenocarcinoma. J Mol Diagn 2006;8: 76-83. (Pubitemid 43257437)
29. Paciucci R, Tora M, Diaz VM, Real FX. The plasminogen activator system in pancreas cancer: role of t-PA in the invasive potential in vitro. Oncogene 1998;16:625-33. (Pubitemid 28062342)
30. Diaz VM, Planaguma J, Thomson TM, Reventos J, Paciucci R. Tissue plasminogen activator is required for the growth, invasion, and angiogenesis of pancreatic tumor cells. Gastroenterology 2002;122:806-19. (Pubitemid 34173834)
31. Nielsen A, Scarlett CJ, Samra JS, Gill A, Li Y, Allen BJ, et al. Significant overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma using real-time quantitative reverse transcription polymerase chain reaction. J Gastroenterol Hepatol 2005;20:256-63. (Pubitemid 40343278)
32. Harvey SR, Hurd TC, Markus G, Martinick MI, Penetrante RM, Tan D, et al. Evaluation of urinary plasminogen activator, its receptor, matrix metalloproteinase-9, and von Willebrand factor in pancreatic cancer. Clin Cancer Res 2003;9:4935-43. (Pubitemid 37323300)
33. Jones LE, Humphreys MJ, Campbell F, Neoptolemos JP, Boyd MT. Comprehensive analysis of matrix metalloproteinase and tissue inhibitor expression in pancreatic cancer: increased expression of matrix metalloproteinase-7 predicts poor survival. Clin Cancer Res 2004;10:2832-45. (Pubitemid 38509163)
34. Chen Y, Zheng B, Robbins DH, Lewin DN, Mikhitarian K, Graham A, et al. Accurate discrimination of pancreatic ductal adenocarcinoma and chronic pancreatitis using multimarker expression data and samples obtained by minimally invasive fine needle aspiration. Int J Cancer 2007;120: 1511-7. (Pubitemid 46355386)